BIOMAT Database Logo BIOMAT Database Logo

Treatment of functional dysmenorrhea; a double-blind study. 1971

R Nakano, and H Takemura

UI MeSH Term Description Entries
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011278 Pregnanes Saturated derivatives of the steroid pregnane. The 5-beta series includes PROGESTERONE and related hormones; the 5-alpha series includes forms generally excreted in the urine.
D011372 Progestins Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. Gestagenic Agent,Progestagen,Progestagenic Agent,Progestational Agent,Progestational Compound,Progestational Hormone,Progestogen,Progestogens,Gestagen,Gestagen Effect,Gestagen Effects,Gestagenic Agents,Gestagenic Effect,Gestagenic Effects,Gestagens,Progestagenic Agents,Progestagens,Progestational Agents,Progestational Compounds,Progestational Hormones,Progestin,Progestin Effect,Progestin Effects,Progestogen Effect,Progestogen Effects,Agent, Gestagenic,Agent, Progestagenic,Agent, Progestational,Compound, Progestational,Effect, Gestagen,Effect, Gestagenic,Effect, Progestin,Effect, Progestogen,Effects, Gestagen,Effects, Gestagenic,Effects, Progestin,Effects, Progestogen,Hormone, Progestational
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004412 Dysmenorrhea Painful menstruation. Menstruation, Painful,Pain, Menstrual,Dysmenorrheas,Menstrual Pain,Menstrual Pains,Menstruations, Painful,Painful Menstruation,Painful Menstruations,Pains, Menstrual
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females

Related Publications

R Nakano, and H Takemura
Treatment of dysmenorrhea. A comparative double blind study.
March 1970, American journal of obstetrics and gynecology,
R Nakano, and H Takemura
TREATMENT OF PRIMARY DYSMENORRHEA: A DOUBLE-BLIND STUDY.
June 1965, JAMA,
R Nakano, and H Takemura
DYSMENORRHEA: TREATMENT WITH PAPAVERINE-DOUBLE BLIND STUDY.
November 1964, Journal of the Medical Association of the State of Alabama,
R Nakano, and H Takemura
Isoxsuprine for the treatment of dysmenorrhea. A double-blind study of 143 subjects.
January 1962, Obstetrics and gynecology,
R Nakano, and H Takemura
Treatment of primary dysmenorrhea with a combined type oral contraceptive--a double blind study.
February 1971, Journal of the American College Health Association,
R Nakano, and H Takemura
Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea--a double-blind study.
January 1997, The American journal of Chinese medicine,
R Nakano, and H Takemura
[Comparative double-blind study of Aclofenac and a placebo in the symptomatic treatment of dysmenorrhea].
January 1971, Revue francaise de gynecologie et d'obstetrique,
R Nakano, and H Takemura
Naproxen in the treatment of OC-resistant primary dysmenorrhea. A double-blind cross-over study.
January 1983, Acta obstetricia et gynecologica Scandinavica. Supplement,
R Nakano, and H Takemura
Ibuprofen and naproxen-sodium in the treatment of primary dysmenorrhea: a double-blind cross-over study.
September 1985, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
R Nakano, and H Takemura
A double-blind cross-over study comparing flurbiprofen with naproxen-sodium for the treatment of primary dysmenorrhea.
January 1989, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!